EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 1
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Asia Pacific

SGS INCREASES BIOSAFETY TESTING CAPACITY AT ITS GLASGOW FACILITY

SGS has just completed a significant expansion project at its Glasgow facility, meaning it can provide increased biosafety testing for the biologics, drug development...
28 October 2021 Asia Pacific | Australasia | Europe | news | North America | Regional News biosafety | BSL-2 laboratories
Continue Reading →
Europe

Tezepelumab is the first biologic to consistently and significantly reduce exacerbations in broad population of severe asthma patients

Tezepelumab demonstrated superiority versus placebo across every primary and keysecondary endpoint in NAVIGATOR Phase III trial Positive full results from the pivo...
1 March 2021 Europe | North America
Continue Reading →
Europe

Cytel expands unique trial for early COVID-19 treatments in Global South

Two South Africa sites added to TOGETHER platform trials for the outpatient treatment of high-risk adults infected with SARS-CoV-2 Pictured: Dr Edward Mills, VP of...
29 September 2020 Europe | news | North America
Continue Reading →
news

ERT Acquires APDM Wearable Technologies to Reinvent Endpoint Measurement in Clinical Trials

Combining APDM’s precision motion wearables and digital biomarkers with ERT’s eClinical Suite revolutionizes clinical trials ERT, the global leader in clinical end...
11 June 2020 news | North America
Continue Reading →
Europe

Over half the nation ‘at risk’ of chronic disease due to obesity

A new NHS report has detailed how more than 56% of adults are at increased, high or very high risk of chronic disease due to their waist circumference and BMI, with ...
4 December 2019 Europe | news | North America
Continue Reading →
news

Merck’s Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?

Currently, five PD-1/L1 inhibitors boast FDA approvals to treat certain bladder cancer patients. But only one of them is about to enter a different segment of the di...
4 December 2019 news | North America
Continue Reading →
news

Unique Alzheimer’s Disease Tau Vaccine Shows Great Potential in Pre-Clinical Studies

MultiTEP Platform-Based Epitope Vaccine Targeting the Phosphatase Activating Domain (PAD) of Tau Shows Clear Therapeutic Efficacy in PS19 Mice Capo Therapeutics, I...
31 October 2019 news | North America
Continue Reading →
news

TSI Reports Enrollment of First 10 Patients in its Phase 2 Ischemic Stroke Clinical Trial and Completion of its Phase 2 Study Protocol in Myocardial Infarction

Studies Aim to Confirm Safety and Efficacy of Novel Bio-inspired Clot-dissolving Therapy Thrombolytic Science, LLC (TSI) today announced progress with 10 patients ...
31 October 2019 news | North America
Continue Reading →
news

HIV vaccine nears clinical trial following new findings

A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide sim...
5 September 2019 news | North America
Continue Reading →
Europe

Velabs to develop novel immune-based therapy for obesity

Announces strategic partnership with alytas therapeutics Velabs Therapeutics GmbH (Velabs), a biotech company focused on the rapid screening of functional therapeu...
5 September 2019 Europe | news | North America
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte